Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. OptiBiotix Health Plc
  6. Summary
    OPTI   GB00BP0RTP38

OPTIBIOTIX HEALTH PLC

(OPTI)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
07/19/2021 07/20/2021 07/21/2021 07/22/2021 07/23/2021 Date
46.5(c) 45.75(c) 47(c) 45.5(c) 45.5(c) Last
222 627 411 279 269 936 195 737 61 086 Volume
-4.12% -1.61% +2.73% -3.19% 0.00% Change
More quotes
Estimated financial data (e)
Sales 2021 2,22 M 3,05 M 3,05 M
Net income 2021 -0,77 M -1,06 M -1,06 M
Net cash position 2021 0,60 M 0,82 M 0,82 M
P/E ratio 2021 -51,7x
Yield 2021 -
Sales 2022
Net income 2022
Net Debt 2022
P/E ratio 2022
Yield 2022
Capitalization 40,0 M 55,0 M 55,0 M
EV / Sales 2021 17,8x
EV / Sales 2022
Nbr of Employees 8
Free-Float 84,8%
More Financials
Company
Optibiotix Health Plc is a life sciences company developing a range of products to modify the human microbiome. The Company's principal activity is research and development into microbiome modulators. It operates in UK segment. The Company has a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest and appetite suppression. The development pipeline is operated by its... 
More about the company
Ratings of OptiBiotix Health Plc
Trading Rating : 
Investor Rating :  -
ESG Refinitiv : 
-
More Ratings
All news about OPTIBIOTIX HEALTH PLC
07/19OPTIBIOTIX HEALTH : ProBiotix enters exclusive South Korean distribution deal fo..
PU
06/17OPTIBIOTIX HEALTH : Results Report
PU
06/17Optibiotix Health plc Reports Earnings Results for the Full Year Ended Decemb..
CI
03/23OPTIBIOTIX HEALTH : Appoints Subsidiary CEO
MT
03/23OptiBiotix Health Plc Directorate Changes
CI
03/02OptiBiotix Health plc Appoints Stephen Hammond MP as Non-Executive Director
CI
01/19OptiBiotix Health plc Appoints Taru Jain as Business Development Director in ..
CI
01/11OptiBiotix Health Plc Announces Joint Research Agreement with Fondazione Edmu..
CI
2020OptiBiotix Health Plc Announces Board Changes
CI
2020OPTIBIOTIX HEALTH : Unit Grants License to Genuine Health For Health Product In ..
MT
2020Optibiotix Health plc Announces Launch of Weight Management Products in Austr..
CI
2020OptiBiotix Health plc Announces Appointment of Aneta Zlotkowskaas as Head of ..
CI
2020OptiBiotix Health Plc Receives FDA Authorisation for an Investigational New D..
CI
2020OptiBiotix Health Plc Enters into Exclusive Distribution Agreement with Unite..
CI
2020Optibiotix Health plc Announces Revenue Guidance for the Full Year 2020
CI
More news
News in other languages on OPTIBIOTIX HEALTH PLC

- No features available -

More news
Chart OPTIBIOTIX HEALTH PLC
Duration : Period :
OptiBiotix Health Plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends OPTIBIOTIX HEALTH PLC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 0,46 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Stephen Patrick O'Hara Chief Executive Officer & Executive Director
Mark Kingsley Collingbourne Chief Financial Officer
Richard Colin Neil Davidson Non-Executive Chairman
Sofia Kolyda Executive Director, Director-R&D
Aneta Zlotkowska Head-Quality & Operations
Sector and Competitors
1st jan.Capi. (M$)
OPTIBIOTIX HEALTH PLC-21.55%61
GILEAD SCIENCES, INC.18.47%85 134
WUXI APPTEC CO., LTD.37.17%71 226
REGENERON PHARMACEUTICALS21.37%57 013
BIONTECH SE245.88%55 555
VERTEX PHARMACEUTICALS-15.16%50 308